NIFTY 50▼21,861.50
-134.35 (-0.61%)
SENSEX▼72,000.86
-488.13 (-0.67%)
NIFTY BANK▼46,744.95
-324.50 (-0.69%)
TATA MOTORS▼964.00
-7.35 (-0.76%)
INDIAN RAILWAY FINANCE CORP▼140.00
-1.95 (-1.37%)
SUZLON ENERGY▼40.45
-0.70 (-1.70%)
TATA POWER▼426.25
-3.50 (-0.81%)
TATA STEEL▼160.00
-0.05 (-0.03%)
YES BANK▼23.65
-0.25 (-1.05%)
INDIAN RENEWABLE ENERGY▼160.00
-3.15 (-1.93%)
RELIANCE INDUSTRIES▼2,913.55
-15.10 (-0.52%)
RELIANCE POWER▼28.00
-0.70 (-2.44%)
HDFC BANK▼1,486.55
-8.15 (-0.55%)
RAIL VIKAS NIGAM▼253.65
-6.25 (-2.40%)
ADANI POWER▼571.00
-27.10 (-4.53%)
VODAFONE IDEA▼12.90
-0.30 (-2.27%)
JIO FIN SERVICES LTD▼378.00
-0.40 (-0.11%)
ZOMATO▼182.30
-2.90 (-1.57%)
NHPC▼88.70
-0.80 (-0.89%)
INDIAN RAILWAY TOURISM CORP▼990.00
-2.95 (-0.30%)
STATE BANK OF INDIA▼734.50
-10.30 (-1.38%)
INDIAN OIL CORP▼163.50
-5.50 (-3.25%)
MRF▼1,28,921.00
-310.50 (-0.24%)
ITC▼418.00
-0.85 (-0.20%)
ADANI GREEN ENERGY▼1,761.20
-14.25 (-0.80%)
ADANI ENTERPRISES▼3,000.00
-19.30 (-0.64%)
JAIPRAKASH POWER VENTURES▼16.60
-0.60 (-3.49%)
ADANI PORT & SEZ▼1,280.00
-15.55 (-1.20%)
Abbott India Share Price
ABBOTINDIA
₹25,990.00-₹75.20 (-0.29%) Past YearLast updated on 19 Apr, 2024 | 09:07 AM IST
₹25,990.00₹25,990.00
LH
What’s in news?
Company overview
About
Market cap
| Open₹25,990.00 | Close₹26,065.20 |
Circuit range₹28,671.70 - ₹23,458.70 | Day range₹25,990.00 - ₹25,990.00 | Year range₹20,605.05 - ₹29,638.95 |
Volume17 | Avg. traded₹25,990.00 | Revenue (12m)₹5,749 Cr |
Abbott IndiaAbbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
Read more
Abbott India Key indicators
52 week high₹29,638.95 | 52 week low₹20,605.05 | P/E ratio48.5 |
P/B ratio | ROE32.07% | ROCE42.93% |
Dividend yield1.25% | Debt/Equity ratio | EPS446.78 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
86%
Hold
0%
Sell
14%
This analysis is based on the reviews of 7 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin24.77% | Net profit margin17.29% |
ROE32.07% | ROA21.71% |
ROCE42.93% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Abbott India Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Apr 18 2024 | ₹26,224.00 | ₹26,065.20 | -0.61% |
Tue, Apr 16 2024 | ₹26,240.00 | ₹26,144.75 | -0.36% |
Mon, Apr 15 2024 | ₹26,444.65 | ₹26,219.75 | -0.86% |
Fri, Apr 12 2024 | ₹26,950.00 | ₹26,444.65 | -1.91% |
Wed, Apr 10 2024 | ₹26,421.00 | ₹27,021.80 | |
Tue, Apr 9 2024 | ₹26,405.00 | ₹26,420.50 | |
Mon, Apr 8 2024 | ₹26,783.80 | ₹26,400.40 | -1.45% |
Fri, Apr 5 2024 | ₹26,699.95 | ₹26,636.90 | -0.24% |
Events
Corporate actions
Dividend • ₹145/share
Ex date 21 Jul 2023
Dividend • ₹180/share
Ex date 21 Jul 2023
Dividend • ₹130/share
Ex date 02 Aug 2022
Dividend • ₹145/share
Ex date 02 Aug 2022
Learn more
Abbott India Futures & Options
View all